Fig. 3From: The relationship between payer type and lipid outcomes in response to clinical lifestyle interventions in youth with dyslipidemiaChange in LDL-C (mg/dL) at baseline through the third follow-up visit among patients with self-reported White race/ethnicity and abnormal LDL-C at baseline and stratified by health coverage payer-type. Data presented are mean and 95% confidence intervals. CI, confidence interval; LDL-C, low density lipoprotein cholesterolBack to article page